canada

COVID-19 vaccine developer CanSino Biologics seeks to elevate 5.2 billion yuan ($742 million) in a secondary public providing by way of the STAR Market, a Nasdaq-like market in Shanghai. China-based CanSino Biologics plans on promoting 24.eight million new shares at 209.71 yuan every, representing the second-highest share worth on this new tech board. The TrialSite
0 Comments
Axel Klein, GDPO Senior Research Associate.April 24, 2019. At the 62nd meeting of the UN Commission on Narcotic Drugs (CND) in March this year the tensions between states with widely diverging drug policies finally came to the surface. On the floor of the plenary meeting the Russian delegation took Canada to task for ‘violating international
0 Comments